press releases

home > press releases

- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- Archives >>

Sep 22 Addex Pharmaceuticals Initiates Phase I Trials with ADX10059, a novel compound intended for Anxiety and Migraine

Jan 26 Addex Pharmaceuticals named by tornado insider among europe's top 100 private tech companies

Jan 17 Addex Pharmaceuticals enters into Collaboration with Ortho-McNeil Pharmaceutical to Develop Novel Treatments for Anxiety, Depression, Schizophrenia and Alzheimer's disease

© 2012, ADDEX Pharmaceuticals